Insider Transactions Reported by 16 Insiders of Vincerx Pharma, Inc.

Location
Palo Alto, CA

Key facts

  • Vincerx Pharma, Inc. has 16 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are not currently available.

Change

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Research use

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 May 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Vincerx Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Christopher P. Lowe Director $37,972 Mixed 24 Aug 2022
Alexander A. Seelenberger Chief Financial Officer $28,745 Filing P/S 12 Aug 2024
Rubric Capital Management LP 10%+ Owner Mixed 20 Jan 2022
Ahmed Hamdy MD Chief Executive Officer, Director Mixed 12 Aug 2024
Andrew I. McDonald Director, 10%+ Owner Mixed 26 May 2022
Brian J. Druker Director Mixed 23 May 2024
Ruth E. Stevens Director Mixed 23 May 2024
Sooin Hwang Chief Business Officer Mixed 14 Feb 2022
Xiaoming Zhang Chief Technology Officer Mixed 14 Feb 2022
Hermes de Jesus Garban Chief Medical Officer Mixed 14 Feb 2022
Raquel E. Izumi President and Chief Operations Officer, Director Mixed 12 Aug 2024
Laura I. Bushnell Director Mixed 23 May 2024
John H. Lee Director Mixed 23 May 2024
Tom C. Thomas General Counsel and Chief Legal Officer Mixed 12 Aug 2024
Francisco D. Salva Director Mixed 23 May 2024
Kevin Haas Acting Chief Financial Officer Mixed 20 Dec 2024

Top shareholders of Vincerx Pharma, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ARMISTICE CAPITAL, LLC
13D/G
5%
274,908
$19,244 -$294,015 31 Mar 2025
Prosight Management, LP
13D/G
5%
111,755
$7,823 $0 31 Dec 2024
Rubric Capital Management LP
3/4/5
10%+ Owner
class O/S missing
2,107,000
20 Jan 2022
Andrew I. McDonald
3/4/5
Director, 10%+ Owner
class O/S missing
15,000
26 May 2022
Christopher P. Lowe
3/4/5
Director
class O/S missing
40,000
$37,972 24 Aug 2022
Alexander A. Seelenberger
3/4/5
Chief Financial Officer
mixed-class rows
155,280
mixed-class rows
$28,745 12 Aug 2024
SAGE RHINO CAPITAL LLC
13D/G
class O/S missing
4,260
$426 $0 29 Jan 2025
Ahmed Hamdy MD
3/4/5
Chief Executive Officer, Director
class O/S missing
200,000
12 Aug 2024
Raquel E. Izumi
3/4/5
President and Chief Operations Officer, Director
class O/S missing
165,000
12 Aug 2024
Tom C. Thomas
3/4/5
General Counsel and Chief Legal Officer
class O/S missing
125,000
12 Aug 2024
Hermes de Jesus Garban
3/4/5
Chief Medical Officer
class O/S missing
55,250
14 Feb 2022
Kevin Haas
3/4/5
Acting Chief Financial Officer
class O/S missing
42,776
20 Dec 2024
Sooin Hwang
3/4/5
Chief Business Officer
class O/S missing
34,000
14 Feb 2022
Xiaoming Zhang
3/4/5
Chief Technology Officer
class O/S missing
34,000
14 Feb 2022
Brian J. Druker
3/4/5
Director
class O/S missing
15,000
23 May 2024
Francisco D. Salva
3/4/5
Director
class O/S missing
15,000
23 May 2024
John H. Lee
3/4/5
Director
class O/S missing
15,000
23 May 2024
Laura I. Bushnell
3/4/5
Director
class O/S missing
15,000
23 May 2024
Ruth E. Stevens
3/4/5
Director
class O/S missing
15,000
23 May 2024

Recent Insider Transactions by Companies or Individuals for Vincerx Pharma, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .